home / stock / dcph / dcph message board
Subject | By | Source | When |
---|---|---|---|
$DCPH and the shorts continue | ALERTS100%to10000%GAIN | investorshub | 05/01/2023 9:24:25 PM |
$DCPH The trading last trade up | ALERTS100%to10000%GAIN | investorshub | 04/28/2023 10:29:39 PM |
$DCPH Have a look at this | ok2buy | investorshub | 04/28/2023 6:15:08 PM |
Thoughts on where this is headed? | Arcglass | investorshub | 04/24/2023 4:59:07 AM |
best news of the day | ALERTS100%to10000%GAIN | investorshub | 04/12/2023 12:44:47 PM |
znewcar1: $DCPH 23% v2,6M c19.76 f67,576M H19.89 ML14.52 | znewcar1 | investorshangout | 01/04/2023 9:21:25 PM |
Management to reduce workforce and rebalancing their efforts | ok2buy | investorshub | 12/08/2021 7:27:09 PM |
$DCPH~~ADX (14) chart,CRAZYY POWER TO BREAK WOWZA starting | ALERTS100%to10000%GAIN | investorshub | 11/22/2021 1:16:08 PM |
$DCPH~~daily and weekly,500%% +++reversal,,https://stockcharts.com/freecha | ALERTS100%to10000%GAIN | investorshub | 11/22/2021 1:14:05 PM |
$DCPH chart,crazyy bottom here,, https://stockcharts.com/h-sc/ui?s=dcph&p= | ALERTS100%to10000%GAIN | investorshub | 11/22/2021 1:12:54 PM |
$DCPH~~$8.96 load all you can now,,CRAZYY$ HUGE NEWS!!! | ALERTS100%to10000%GAIN | investorshub | 11/22/2021 1:12:19 PM |
AviseAnalytics: AFTER A SETBACK, WHATS NEXT FOR DECIPHERA PHARMACEUTICALS? $DCPH Clinical-stage | AviseAnalytics | investorshangout | 11/10/2021 12:05:57 PM |
I agree, the dollar volume was insane on | Just brooke | investorshub | 11/08/2021 1:08:33 AM |
Should be a good bounce coming. | Arcglass | investorshub | 11/08/2021 12:13:11 AM |
Stong buy and hold imo.... | Just brooke | investorshub | 11/06/2021 5:21:27 PM |
AviseAnalytics: 4 BIOTECH STOCKS INSIDERS ARE SELLING! $DCPH $RAPT $FGEN $SGTX Insider selling | AviseAnalytics | investorshangout | 10/12/2021 12:22:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Deciphera Pharmaceuticals Inc. Company Name:
DCPH Stock Symbol:
NASDAQ Market:
2024-03-21 19:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-11 17:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– Fourth Quarter 2023 Total Revenue of $48.3 Million and Full Year 2023 Revenue of $163.4 Million; QINLOCK ® Net Product Revenue Increased 27% to $159.1 Million in 2023 Compared to 2022 – – Expects to Submit NDA for Vimseltinib in the Second Quarter of 20...